GIMBE - News Cliniche - Pagina 28

Home

News Cliniche - Pagina 28

ONLINE IL SITO GIMBE SULL'EMERGENZA COVID-19

News Cliniche

GIMBE: Eventi, progetti, pubblicazioni e altre attività istituzionali della Fondazione GIMBE
Metodologiche: articoli pertinenti le aree del know-how GIMBE, pubblicati nei top-six journals*
Cliniche: articoli di ricerca clinica primaria e secondaria pubblicati nei top-six journals*
Sanità: notizie dalla sanità italiana
Eventi: congressi, conferenze, workshop nazionali e internazionali relativi alle aree del know-how GIMBE

*N Engl J Med, Lancet, Ann Intern Med, JAMA, BMJ, PLos Med

28 gennaio 2017

Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial

Lancet 2017;389:369-380

Mesh, graft, or standard repair for women having primary transvaginal anterior or posterior compartment prolapse surgery: two parallel-group, multicentre, randomised, controlled trials (PROSPECT)

Lancet 2017;389:381-392

Pelvic floor muscle training for secondary prevention of pelvic organ prolapse (PREVPROL): a multicentre randomised controlled trial

Lancet 2017;389:393-402

26 gennaio 2017

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection

N Engl J Med 2017;376:305-317

Therapeutic Hypothermia after In-Hospital Cardiac Arrest in Children

N Engl J Med 2017;376:318-329

21 gennaio 2017

Two-step egg introduction for prevention of egg allergy in high-risk infants with eczema (PETIT): a randomised, double-blind, placebo-controlled trial

Lancet 2017;389:276-286

Low back pain and sciatica: summary of NICE guidance

BMJ 2017;356:i6748

Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials

BMJ 2017;356:j4

External validation and comparison of three prediction tools for risk of osteoporotic fractures using data from population based electronic health records: retrospective cohort study

BMJ 2017;356:i6755

19 gennaio 2017

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

N Engl J Med 2017;376:209-220

26

27

28

29

30

Pagina aggiornata il 04/05/2024